160 related articles for article (PubMed ID: 9517769)
1. Induction of remission in Wegener's granulomatosis with low dose methotrexate.
de Groot K; Mühler M; Reinhold-Keller E; Paulsen J; Gross WL
J Rheumatol; 1998 Mar; 25(3):492-5. PubMed ID: 9517769
[TBL] [Abstract][Full Text] [Related]
2. Treatment of non-life threatening Wegener's granulomatosis with methotrexate and daily prednisone as the initial therapy of choice.
Stone JH; Tun W; Hellman DB
J Rheumatol; 1999 May; 26(5):1134-9. PubMed ID: 10332980
[TBL] [Abstract][Full Text] [Related]
3. High rate of renal relapse in 71 patients with Wegener's granulomatosis under maintenance of remission with low-dose methotrexate.
Reinhold-Keller E; Fink CO; Herlyn K; Gross WL; De Groot K
Arthritis Rheum; 2002 Jun; 47(3):326-32. PubMed ID: 12115164
[TBL] [Abstract][Full Text] [Related]
4. Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis.
Metzler C; Miehle N; Manger K; Iking-Konert C; de Groot K; Hellmich B; Gross WL; Reinhold-Keller E;
Rheumatology (Oxford); 2007 Jul; 46(7):1087-91. PubMed ID: 17519271
[TBL] [Abstract][Full Text] [Related]
5. Use of methotrexate and glucocorticoids in the treatment of Wegener's granulomatosis. Long-term renal outcome in patients with glomerulonephritis.
Langford CA; Talar-Williams C; Sneller MC
Arthritis Rheum; 2000 Aug; 43(8):1836-40. PubMed ID: 10943874
[TBL] [Abstract][Full Text] [Related]
6. Baseline features and initial treatment as predictors of remission and relapse in Wegener's granulomatosis.
Koldingsnes W; Nossent JC
J Rheumatol; 2003 Jan; 30(1):80-8. PubMed ID: 12508394
[TBL] [Abstract][Full Text] [Related]
7. Azathioprine or methotrexate maintenance for ANCA-associated vasculitis.
Pagnoux C; Mahr A; Hamidou MA; Boffa JJ; Ruivard M; Ducroix JP; Kyndt X; Lifermann F; Papo T; Lambert M; Le Noach J; Khellaf M; Merrien D; Puéchal X; Vinzio S; Cohen P; Mouthon L; Cordier JF; Guillevin L;
N Engl J Med; 2008 Dec; 359(26):2790-803. PubMed ID: 19109574
[TBL] [Abstract][Full Text] [Related]
8. Maintenance of remission with leflunomide in Wegener's granulomatosis.
Metzler C; Fink C; Lamprecht P; Gross WL; Reinhold-Keller E
Rheumatology (Oxford); 2004 Mar; 43(3):315-20. PubMed ID: 14963200
[TBL] [Abstract][Full Text] [Related]
9. Etanercept plus standard therapy for Wegener's granulomatosis.
Wegener's Granulomatosis Etanercept Trial (WGET) Research Group
N Engl J Med; 2005 Jan; 352(4):351-61. PubMed ID: 15673801
[TBL] [Abstract][Full Text] [Related]
10. Intravenous immunoglobulins for relapses of systemic vasculitides associated with antineutrophil cytoplasmic autoantibodies: results of a multicenter, prospective, open-label study of twenty-two patients.
Martinez V; Cohen P; Pagnoux C; Vinzio S; Mahr A; Mouthon L; Sailler L; Delaunay C; Sadoun A; Guillevin L;
Arthritis Rheum; 2008 Jan; 58(1):308-17. PubMed ID: 18163506
[TBL] [Abstract][Full Text] [Related]
11. Wegener's granulomatosis: a challenging disease for otorhinolaryngologists.
Cadoni G; Prelajade D; Campobasso E; Calŏ L; Agostino S; Manna R; Paludetti G
Acta Otolaryngol; 2005 Oct; 125(10):1105-10. PubMed ID: 16298794
[TBL] [Abstract][Full Text] [Related]
12. A staged approach to the treatment of Wegener's granulomatosis: induction of remission with glucocorticoids and daily cyclophosphamide switching to methotrexate for remission maintenance.
Langford CA; Talar-Williams C; Barron KS; Sneller MC
Arthritis Rheum; 1999 Dec; 42(12):2666-73. PubMed ID: 10616016
[TBL] [Abstract][Full Text] [Related]
13. Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safety.
Stone JH; Uhlfelder ML; Hellmann DB; Crook S; Bedocs NM; Hoffman GS
Arthritis Rheum; 2001 May; 44(5):1149-54. PubMed ID: 11352248
[TBL] [Abstract][Full Text] [Related]
14. Therapy for the maintenance of remission in sixty-five patients with generalized Wegener's granulomatosis. Methotrexate versus trimethoprim/sulfamethoxazole.
de Groot K; Reinhold-Keller E; Tatsis E; Paulsen J; Heller M; Nölle B; Gross WL
Arthritis Rheum; 1996 Dec; 39(12):2052-61. PubMed ID: 8961911
[TBL] [Abstract][Full Text] [Related]
15. An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients.
Reinhold-Keller E; Beuge N; Latza U; de Groot K; Rudert H; Nölle B; Heller M; Gross WL
Arthritis Rheum; 2000 May; 43(5):1021-32. PubMed ID: 10817555
[TBL] [Abstract][Full Text] [Related]
16. Clinical features and outcome of pediatric Wegener's granulomatosis.
Akikusa JD; Schneider R; Harvey EA; Hebert D; Thorner PS; Laxer RM; Silverman ED
Arthritis Rheum; 2007 Jun; 57(5):837-44. PubMed ID: 17530684
[TBL] [Abstract][Full Text] [Related]
17. [Wegener's granulomatosis in ENT: clinical presentation, diagnosis and therapy].
Tesche S; Münscher A; Metternich FU
Laryngorhinootologie; 2007 Nov; 86(11):775-9. PubMed ID: 17724622
[TBL] [Abstract][Full Text] [Related]
18. Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).
Seo P; Min YI; Holbrook JT; Hoffman GS; Merkel PA; Spiera R; Davis JC; Ytterberg SR; St Clair EW; McCune WJ; Specks U; Allen NB; Luqmani RA; Stone JH;
Arthritis Rheum; 2005 Jul; 52(7):2168-78. PubMed ID: 15986348
[TBL] [Abstract][Full Text] [Related]
19. Meningeal involvement in Wegener's granulomatosis.
Al Dhanhani A; Macaulay R; Maloney B; Hanly JG
J Rheumatol; 2006 Feb; 33(2):364-7. PubMed ID: 16465672
[TBL] [Abstract][Full Text] [Related]
20. Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease.
Fautrel B; Borget C; Rozenberg S; Meyer O; Le Loët X; Masson C; Koeger AC; Kahn MF; Bourgeois P
J Rheumatol; 1999 Feb; 26(2):373-8. PubMed ID: 9972972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
